Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Flechtner

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
European Journal of Haematology|February 11, 2021
Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivorsHugo Vachon, Justyna Mierzynska, Mekdes Taye, et al.
Journal of the National Cancer Institute|December 14, 2011
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survivalChantal Quinten, John Maringwa, Carolyn C Gotay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2020
Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study GroupStefanie Kreissl, Horst Müller, Helen Goergen, et al.
European Journal of Cancer Care|March 10, 2009
Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: a new international initiativeAndrew Bottomley, Chantal Quinten, Corneel Coens, et al.
Neuro-Oncology|February 18, 2021
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patientsLinda Dirven, Jammbe Z Musoro, Corneel Coens, et al.
Psycho-Oncology|June 22, 2019
Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): Results from the international psychometric validationJoachim Weis, Markus A Wirtz, Krzysztof A Tomaszewski, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 1, 2011
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 dataFrancesca Martinelli, Chantal Quinten, John T Maringwa, et al.
Cancer|October 16, 2013
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sitesChantal Quinten, Francesca Martinelli, Corneel Coens, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 2, 2010
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trialsJohn T Maringwa, Chantal Quinten, Madeleine King, et al.
Journal of the National Cancer Institute|December 31, 2015
The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE InitiativeEfstathios Zikos, Corneel Coens, Chantal Quinten, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
European Journal of Haematology|February 11, 2021
Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivorsHugo Vachon, Justyna Mierzynska, Mekdes Taye, et al.
Journal of the National Cancer Institute|December 14, 2011
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survivalChantal Quinten, John Maringwa, Carolyn C Gotay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2020
Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study GroupStefanie Kreissl, Horst Müller, Helen Goergen, et al.
European Journal of Cancer Care|March 10, 2009
Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: a new international initiativeAndrew Bottomley, Chantal Quinten, Corneel Coens, et al.
Neuro-Oncology|February 18, 2021
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patientsLinda Dirven, Jammbe Z Musoro, Corneel Coens, et al.
Psycho-Oncology|June 22, 2019
Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): Results from the international psychometric validationJoachim Weis, Markus A Wirtz, Krzysztof A Tomaszewski, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 1, 2011
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 dataFrancesca Martinelli, Chantal Quinten, John T Maringwa, et al.
Cancer|October 16, 2013
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sitesChantal Quinten, Francesca Martinelli, Corneel Coens, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 2, 2010
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trialsJohn T Maringwa, Chantal Quinten, Madeleine King, et al.
Journal of the National Cancer Institute|December 31, 2015
The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE InitiativeEfstathios Zikos, Corneel Coens, Chantal Quinten, et al.
Pageof 10